Form 8-K - Current report:
SEC Accession No. 0001193805-25-000212
Filing Date
2025-02-20
Accepted
2025-02-20 07:30:56
Documents
31
Period of Report
2025-02-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e664213_8k-immunic.htm   iXBRL 8-K 22935
2 e664213_ex99-1.htm EX-99.1 25144
3 e664213_ex99-2.htm EX-99.2 11183
7 GRAPHIC image_001.jpg GRAPHIC 3195
8 GRAPHIC slide1.jpg GRAPHIC 53766
9 GRAPHIC slide2.jpg GRAPHIC 352219
10 GRAPHIC slide3.jpg GRAPHIC 189455
11 GRAPHIC slide4.jpg GRAPHIC 176160
12 GRAPHIC slide5.jpg GRAPHIC 186649
13 GRAPHIC slide6.jpg GRAPHIC 146300
14 GRAPHIC slide7.jpg GRAPHIC 178793
15 GRAPHIC slide8.jpg GRAPHIC 146911
16 GRAPHIC slide9.jpg GRAPHIC 188688
17 GRAPHIC slide10.jpg GRAPHIC 158845
18 GRAPHIC slide11.jpg GRAPHIC 169699
19 GRAPHIC slide12.jpg GRAPHIC 223827
20 GRAPHIC slide13.jpg GRAPHIC 141447
21 GRAPHIC slide14.jpg GRAPHIC 37149
22 GRAPHIC slide15.jpg GRAPHIC 123447
  Complete submission text file 0001193805-25-000212.txt   3655406

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE imux-20250220.xsd EX-101.SCH 3003
5 XBRL LABEL FILE imux-20250220_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE imux-20250220_pre.xml EX-101.PRE 22351
33 EXTRACTED XBRL INSTANCE DOCUMENT e664213_8k-immunic_htm.xml XML 3785
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36201 | Film No.: 25643282
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)